-
Signature
-
/s/ Sheryl Southwick, Attorney-in-fact
-
Stock symbol
-
TNET
-
Transactions as of
-
Nov 7, 2023
-
Transactions value $
-
-$123,114
-
Form type
-
4
-
Date filed
-
11/9/2023, 05:42 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
TNET |
Common Stock |
Options Exercise |
$45.6K |
+1.36K |
+0.8% |
$33.51 |
172K |
Nov 7, 2023 |
Direct |
F1, F2 |
transaction |
TNET |
Common Stock |
Sale |
-$144K |
-1.36K |
-0.79% |
$106.23 |
171K |
Nov 7, 2023 |
Direct |
F2, F3, F4 |
transaction |
TNET |
Common Stock |
Options Exercise |
$11.2K |
+334 |
+0.2% |
$33.51 |
171K |
Nov 8, 2023 |
Direct |
F1, F2 |
transaction |
TNET |
Common Stock |
Sale |
-$35.4K |
-334 |
-0.2% |
$106.01 |
171K |
Nov 8, 2023 |
Direct |
F2, F3, F5 |
holding |
TNET |
Common Stock |
|
|
|
|
|
355K |
Nov 7, 2023 |
By Trust |
F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
TNET |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-1.36K |
-19.49% |
$0.00 |
5.62K |
Nov 7, 2023 |
Common Stock |
1.36K |
$33.51 |
Direct |
F1, F7 |
transaction |
TNET |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-334 |
-5.95% |
$0.00 |
5.28K |
Nov 8, 2023 |
Common Stock |
334 |
$33.51 |
Direct |
F1, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: